22.626 articles found

Hiccups associated with levodopa in Parkinson's disease.

Gerschlager W, Bloem BR.

Mov Disord · 2009-03-01

DOI: 10.1002/mds.22395PMID: 19185020

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.

Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Höglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, Kretzschmar H, Lang AE, Litvan I, Lucas JJ, McGeer PL, Melquist S, Oertel W, Otto M, Paviour D, Reum T, Saint-Raymond A, Steele JC, Tolnay M, Tumani H, van Swieten JC, Vanier MT, Vonsattel JP, Wagner S, Wszolek ZK, Reisensburg Working Group for Tauopathies With Parkinsonism.

Eur J Neurol · 2009-03-01

DOI: 10.1111/j.1468-1331.2008.02513.xPMID: 19364361

Pathological gambling and hypersexuality due to dopaminergic treatment in Parkinson' disease.

Martín Fernández F, Martín González T.

Actas Esp Psiquiatr · 2009-03-01

PMID: 19401861

Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.

Uttara B, Singh AV, Zamboni P, Mahajan RT.

Curr Neuropharmacol · 2009-03-01

DOI: 10.2174/157015909787602823PMID: 19721819

Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy.

Dupiereux I, Zorzi W, Quadrio I, Perret-Liaudet A, Kovacs GG, Heinen E, Elmoualij B.

Cent Nerv Syst Agents Med Chem · 2009-03-01

DOI: 10.2174/187152409787601950PMID: 20021333

Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease.

Sujith OK, Lane C.

Ther Adv Neurol Disord · 2009-03-01

DOI: 10.1177/1756285608101378PMID: 21180645

A treatment for Parkinson's disease, but no improvement for dementia.

Sander R.

Nurs Older People · 2009-03-01

DOI: 10.7748/nop.21.2.31.s28PMID: 27745095

Exploring the therapeutic role of creatine supplementation.

Gualano B, Artioli GG, Poortmans JR, Lancha Junior AH.

Amino Acids · 2009-03-01

DOI: 10.1007/s00726-009-0263-6PMID: 19253023

Scientific rationale for the development of gene therapy strategies for Parkinson's disease.

Björklund T, Kirik D.

Biochim Biophys Acta · 2009-02-27

DOI: 10.1016/j.bbadis.2009.02.009PMID: 19254760

PHENOXY-PIPERIDINES FOR THE TREATMENT OF DISEASES SUCH AS SCHIZOPHRENIA AND DEPRESSION

HOLZEMANN GUNTER, PRUCHER HELMUT, SCHIEMANN KAI, LEIBROCK JOACHIM, GREINER HARTMUT, BURGER CHRISTA, VON MELCHNER LAURIE.

· 2009-02-26

N-PHENYL-PRENYLAMINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

MARTINEZ GIL ANA, CASTRO MORERA ANA, MEDINA PADILLA MIGUEL, MUNOZ RUIZ PILAR, LOPEZ OGALLA JAVIER, GARCIA PALOMERO ESTHER, DE AUSTRIA DE LUQUE CELIA, USAN EGEA PAOLA, VALENZUELA LIMINANA RITA, GARCIA FERNANDEZ PABLO, DELGADO HERNANDEZ ELENA, PEREZ FERNANDEZ DANIEL IGNACIO.

· 2009-02-24

PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

MARTINEZ GIL ANA, CASTRO MORERA ANA, MEDINA PADILLA MIGUEL, MUNOZ RUIZ PILAR, LOPEZ OGALLA JAVIER, RUBIO ARRIETA LAURA, GARCIA PALOMERO ESTHER, GARCIA FERNANDEZ PABLO, DE AUSTRIA DE LUQUE CELIA, DELGADO HERNANDEZ ELENA, USAN EGEA PAOLA, VALENZUELA LIMINANA RITA, SANCHEZ QUESADA JORGE.

· 2009-02-23